213 related articles for article (PubMed ID: 20813773)
1. Validity of an Internet version of the Multiple Sclerosis Neuropsychological Questionnaire.
Akbar N; Honarmand K; Kou N; Levine B; Rector N; Feinstein A
Mult Scler; 2010 Dec; 16(12):1500-6. PubMed ID: 20813773
[TBL] [Abstract][Full Text] [Related]
2. Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes.
O'Brien A; Gaudino-Goering E; Shawaryn M; Komaroff E; Moore NB; DeLuca J
Arch Clin Neuropsychol; 2007 Nov; 22(8):933-48. PubMed ID: 17851031
[TBL] [Abstract][Full Text] [Related]
3. Validation and interpretation of the Dutch version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.
Sonder JM; Mokkink LB; van der Linden FA; Polman CH; Uitdehaag BM
J Neurol Sci; 2012 Sep; 320(1-2):91-6. PubMed ID: 22805106
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Argentina.
Vanotti S; Benedict RH; Acion L; Cáceres F;
Mult Scler; 2009 Feb; 15(2):244-50. PubMed ID: 18845653
[TBL] [Abstract][Full Text] [Related]
5. Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire.
Benedict RH; Munschauer F; Linn R; Miller C; Murphy E; Foley F; Jacobs L
Mult Scler; 2003 Feb; 9(1):95-101. PubMed ID: 12617275
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.
Morrow SA; O'Connor PW; Polman CH; Goodman AD; Kappos L; Lublin FD; Rudick RA; Jurgensen S; Paes D; Forrestal F; Benedict RH
Mult Scler; 2010 Nov; 16(11):1385-92. PubMed ID: 20739335
[TBL] [Abstract][Full Text] [Related]
7. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
Benedict RH; Duquin JA; Jurgensen S; Rudick RA; Feitcher J; Munschauer FE; Panzara MA; Weinstock-Guttman B
Mult Scler; 2008 Aug; 14(7):940-6. PubMed ID: 18573822
[TBL] [Abstract][Full Text] [Related]
8. Interpreting patient/informant discrepancies of reported cognitive symptoms in MS.
Carone DA; Benedict RH; Munschauer FE; Fishman I; Weinstock-Guttman B
J Int Neuropsychol Soc; 2005 Sep; 11(5):574-83. PubMed ID: 16212684
[TBL] [Abstract][Full Text] [Related]
9. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis.
Portaccio E; Goretti B; Zipoli V; Siracusa G; Sorbi S; Amato MP
Clin Neuropsychol; 2009 Feb; 23(2):268-75. PubMed ID: 18609336
[TBL] [Abstract][Full Text] [Related]
10. The Audio Recorded Cognitive Screen (ARCS) in patients with multiple sclerosis: a practical tool for multiple sclerosis clinics.
Lechner-Scott J; Kerr T; Spencer B; Agland S; Lydon A; Schofield PW
Mult Scler; 2010 Sep; 16(9):1126-33. PubMed ID: 20621944
[TBL] [Abstract][Full Text] [Related]
11. Predicting neuropsychological abnormalities in multiple sclerosis.
Benedict RH; Zivadinov R
J Neurol Sci; 2006 Jun; 245(1-2):67-72. PubMed ID: 16626751
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
Rogers JM; Panegyres PK
J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
[TBL] [Abstract][Full Text] [Related]
14. Integration of cognitive impairment in the expanded disability status scale of 215 patients with multiple sclerosis.
Brissart H; Sauvée M; Latarche C; Dillier C; Debouverie M
Eur Neurol; 2010; 64(6):345-50. PubMed ID: 21071951
[TBL] [Abstract][Full Text] [Related]
15. Validity and reliability of a Persian translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Eshaghi A; Riyahi-Alam S; Roostaei T; Haeri G; Aghsaei A; Aidi MR; Pouretemad HR; Zarei M; Farhang S; Saeedi R; Nazeri A; Ganjgahi H; Etesam F; Azimi AR; Benedict RH; Sahraian MA
Clin Neuropsychol; 2012; 26(6):975-84. PubMed ID: 22681459
[TBL] [Abstract][Full Text] [Related]
16. Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test.
Claesson IM; Ytterberg C; Johansson S; Almkvist O; von Koch L
Mult Scler; 2007 Mar; 13(2):272-4. PubMed ID: 17439898
[TBL] [Abstract][Full Text] [Related]
17. [Orbitofrontal dysfunction in multiple sclerosis: Iowa Gambling Task].
García-Molina A; Rodríguez Rajo P; Vendrell Gómez P; Junqué i Plaja C; Roig-Rovira T
Psicothema; 2008 Aug; 20(3):445-9. PubMed ID: 18674441
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH
Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311
[TBL] [Abstract][Full Text] [Related]
19. Reliable screening for neuropsychological impairment in multiple sclerosis.
Benedict RH; Cox D; Thompson LL; Foley F; Weinstock-Guttman B; Munschauer F
Mult Scler; 2004 Dec; 10(6):675-8. PubMed ID: 15584493
[TBL] [Abstract][Full Text] [Related]
20. [Neuropsychological evaluation in multiple sclerosis].
Arnett P; Forn C
Rev Neurol; 2007 Feb 1-15; 44(3):166-72. PubMed ID: 17285522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
